Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

NCT02429258 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes

Interventions

DRUG: Farxiga
DRUG: Placebo
DRUG: Metformin
DRUG: Insulin

Sponsor

AstraZeneca